DeepCurrents Investment Group’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

DeepCurrents Investment Group’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,730	Closed	-$179K	–	190
2022 Q4	$179K	Hold	17,730	–	–	0.01%	158
2022 Q3	$176K	Hold	17,730	–	–	0.01%	175
2022 Q2	$174K	Hold	17,730	–	–	0.01%	175
2022 Q1	$173K	Hold	17,730	–	–	0.01%	185
2021 Q4	$172K	Buy	+17,730	New	+$173K	0.01%	173

DeepCurrents Investment Group's EBAC Position: Q1 2023 in Review

DeepCurrents Investment Group sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 17,730 shares — an estimated $179K sold.

DeepCurrents Investment Group first reported a position in EBAC in Q4 2021 and held it in 5 quarters. The position peaked at $179K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

DeepCurrents Investment Group reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
DeepCurrents Investment Group sold 17,730 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $179K.
DeepCurrents Investment Group first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
DeepCurrents Investment Group's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $179K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on DeepCurrents Investment Group's 13F filing for Q1 2023, filed 15 May 2023.